These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 21169793)

  • 1. p38 Mitogen-activated protein kinase activation by nerve growth factor in primary sensory neurons upregulates μ-opioid receptors to enhance opioid responsiveness toward better pain control.
    Yamdeu RS; Shaqura M; Mousa SA; Schäfer M; Droese J
    Anesthesiology; 2011 Jan; 114(1):150-61. PubMed ID: 21169793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced number, G protein coupling, and antinociceptive efficacy of spinal mu-opioid receptors in diabetic rats are reversed by nerve growth factor.
    Shaqura M; Khalefa BI; Shakibaei M; Winkler J; Al-Khrasani M; Fürst S; Mousa SA; Schäfer M
    J Pain; 2013 Jul; 14(7):720-30. PubMed ID: 23623572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain.
    Mousa SA; Cheppudira BP; Shaqura M; Fischer O; Hofmann J; Hellweg R; Schäfer M
    Brain; 2007 Feb; 130(Pt 2):502-13. PubMed ID: 17142830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine upregulates functional expression of neurokinin-1 receptor in neurons.
    Wan Q; Douglas SD; Wang X; Kolson DL; O'Donnell LA; Ho WZ
    J Neurosci Res; 2006 Nov; 84(7):1588-96. PubMed ID: 16983662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
    Chen SR; Pan HL
    J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased level of neuronal phosphoinositide 3-kinase gamma by the activation of mu-opioid receptor in the mouse periaqueductal gray matter: further evidence for the implication in morphine-induced antinociception.
    Narita M; Imai S; Narita M; Kasukawa A; Yajima Y; Suzuki T
    Neuroscience; 2004; 124(3):515-21. PubMed ID: 14980723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into mechanisms of opioid inhibitory effects on capsaicin-induced TRPV1 activity during painful diabetic neuropathy.
    Shaqura M; Khalefa BI; Shakibaei M; Zöllner C; Al-Khrasani M; Fürst S; Schäfer M; Mousa SA
    Neuropharmacology; 2014 Oct; 85():142-50. PubMed ID: 24863039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral axonal injury results in reduced mu opioid receptor pre- and post-synaptic action in the spinal cord.
    Kohno T; Ji RR; Ito N; Allchorne AJ; Befort K; Karchewski LA; Woolf CJ
    Pain; 2005 Sep; 117(1-2):77-87. PubMed ID: 16098668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of mu- and kappa-opioid receptors as potential targets to regulate parasympathetic, sympathetic, and sensory neurons within rat intracardiac ganglia.
    Mousa SA; Shaqura M; Schäper J; Huang W; Treskatsch S; Habazettl H; Abdul-Khaliq H; Schäfer M
    J Comp Neurol; 2010 Sep; 518(18):3836-47. PubMed ID: 20653037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve growth factor-induced stimulation of p38 mitogen-activated protein kinase in PC12 cells is partially mediated via G(i/o) proteins.
    Yung LY; Tso PH; Wu EH; Yu JC; Ip NY; Wong YH
    Cell Signal; 2008 Aug; 20(8):1538-44. PubMed ID: 18508236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of extracellular signal-regulated protein kinase in the dorsal root ganglion following inflammation near the nerve cell body.
    Obata K; Yamanaka H; Dai Y; Mizushima T; Fukuoka T; Tokunaga A; Noguchi K
    Neuroscience; 2004; 126(4):1011-21. PubMed ID: 15207334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
    Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic arthritis down-regulates peripheral mu-opioid receptor expression with concomitant loss of endomorphin 1 antinociception.
    Li Z; Proud D; Zhang C; Wiehler S; McDougall JJ
    Arthritis Rheum; 2005 Oct; 52(10):3210-9. PubMed ID: 16200625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
    Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons.
    Zollner C; Shaqura MA; Bopaiah CP; Mousa S; Stein C; Schafer M
    Mol Pharmacol; 2003 Aug; 64(2):202-10. PubMed ID: 12869624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression of C fibre-evoked spinal field potentials by the spinal delta opioid receptor is enhanced in the spinal nerve ligation model of neuropathic pain: involvement of the mu-subtype.
    Buesa I; Urrutia A; Aira Z; Salgueiro M; Bilbao J; Mozas M; Aguilera L; Zimmermann M; Azkue JJ
    Neuropharmacology; 2008 Dec; 55(8):1376-82. PubMed ID: 18775732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociception following application of DAMGO to the basolateral amygdala results from a direct interaction of DAMGO with Mu opioid receptors in the amygdala.
    Shin MS; Helmstetter FJ
    Brain Res; 2005 Dec; 1064(1-2):56-65. PubMed ID: 16289487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted Mu opioid agonist with antihyperalgesic activity: II. In vivo pharmacological characterization in the rat.
    Whiteside GT; Harrison JE; Pearson MS; Chen Z; Fundytus ME; Rotshteyn Y; Turchin PI; Pomonis JD; Mark L; Walker K; Broglé KC
    J Pharmacol Exp Ther; 2004 Aug; 310(2):793-9. PubMed ID: 15054116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
    Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
    Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.